GDF15 and metabolic syndrome: GDF15 levels correlated positively with parameters indicative of altered metabolism (dyslipidemia, insulin resistance, metabolic syndrome) and inflammation) but did not correlate with currently used indices of CVR (Framingham score, D:A:D score) when age-adjusted.